Announcements Trials
Browse Landscape

Status

Completed 4Unknown 2Recruiting 2Withdrawn 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 33Breast Neoplasms 32Lung Neoplasms 17Colorectal Neoplasms 16Prostatic Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Hematologic Neoplasms 12Stomach Neoplasms 11Pancreatic Neoplasms 11Carcinoma, Hepatocellular 11Diabetes Mellitus 9Melanoma 7Disease 7Colonic Neoplasms 7Pulmonary Disease, Chronic Obstructive 6Cardiovascular Diseases 6Barrett Esophagus 6Urinary Bladder Neoplasms 5Rectal Neoplasms 5Liver Neoplasms 5Leukemia, Myeloid, Acute 5Fatigue 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Pheochromocytoma 4Myasthenia Gravis 4Multiple Myeloma 4Lymphoma, Non-Hodgkin 4Lymphoma 4Lymphatic Metastasis 4Leiomyoma 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Observational × Myositis × Clear all
NCT02422875 2025-09-30

Comparative Autoantibody and Immunologic Cell Marker Study

Emory University

Enrolling by invitation
2,500 enrolled

Undifferentiated Connective Tissue Diseases, Immunoglobulin G4-Related Disease, Acquired Immunodeficiency Syndrome, Arthritis, Arthritis, Juvenile, Arthritis, Rheumatoid, Autoimmune Diseases, Communicable Diseases, Graft vs Host Disease, Hepatitis C, Lupus Erythematosus, Systemic, Myositis, Sjogren's Syndrome, Purpura, Thrombocytopenic, Idiopathic, Sepsis, Epstein-Barr Virus Infections, Guillain-Barre Syndrome, Scleroderma, Diffuse, Autoimmune Lymphoproliferative Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡